GEJ Tumor
Showing 1 - 25 of >10,000
Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach Trial in Bengbu (HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care
Recruiting
- Adenocarcinoma - GEJ
- Adenocarcinoma of the Stomach
- HER2 Tumor Vaccine
- HER2 Tumor Vaccine+ Standard of Care chemotherapy
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Apr 6, 2022
Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
- Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 18, 2023
HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)
Not yet recruiting
- HER2-positive
- +6 more
- sintilimab
- +2 more
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 28, 2022
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Wuwei, Shanghai (HLX07+HLX10+oxaliplatin+capecitabine,
Recruiting
- Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
-
Wuwei, Gansu, China
- +1 more
Apr 25, 2022
Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)
Recruiting
- Ovarian Cancer, Epithelial
- +14 more
-
Sutton, Surrey, United Kingdom
- +6 more
Jul 22, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Tadalafil 20 MG
-
Tucson, ArizonaArizona Cancer Center at UMC North/University Medical Center
Feb 1, 2023
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Gastric Cancer, GastroEsophageal Cancer Trial in Hong Kong (NovoTTF-100L(P), Oxaliplatin, Capecitabine)
Unknown status
- Gastric Cancer
- GastroEsophageal Cancer
- NovoTTF-100L(P)
- +3 more
-
Hong Kong, Hong KongQueen Mary Hospital
Jun 24, 2020
Esophagus Cancer, Adenocarcinoma Trial (BioXmark™)
Recruiting
- Esophagus Cancer, Adenocarcinoma
- BioXmark™
-
Copenhagen, DenmarkRigshopitalet, Department of Surgery and Transplantation
Nov 7, 2022
Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,
Active, not recruiting
- Gastric Cancer
- +2 more
- margetuximab
- +4 more
-
Scottsdale, Arizona
- +72 more
Aug 24, 2022
MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)
Not yet recruiting
- MSI-H/dMMR Gastroesophageal-junction Cancer
- MSI-H/dMMR Gastric Cancer
- S095029
- Pembrolizumab 200 mg
- (no location specified)
Oct 30, 2023
Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)
Recruiting
- Adenocarcinoma Esophagus
- Circulating tumor DNA(ctDNA) level measurement
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
May 23, 2022
Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)
Recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- hybrid PET/MRI
-
Milano, ItalyDeaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- 5-Fluorouracil
- +4 more
-
Aachen, Germany
- +14 more
Sep 7, 2022
Gastric Cancer Trial in Zhengzhou (Fruquintinib + RC48)
Not yet recruiting
- Gastric Cancer
- Fruquintinib + RC48
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Feb 6, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,
Recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- Pembrolizumab
- +2 more
-
Aurora, Colorado
- +2 more
Jan 4, 2023
OGT Method Versus the Traditional Overlap Method
Completed
- Gastric Cancer
- The overlap guiding tube(OGT) method
- The conventional overlap method
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Jul 1, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)
Active, not recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Atezolizumab
- +4 more
-
Frankfurt, Germany
- +1 more
Apr 14, 2022
HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,
Recruiting
- HER2-positive Gastric Cancer
- Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
- Cinrebafusp alfa (PRS-343) in combination with tucatinib
-
Santa Barbara, California
- +3 more
Jan 14, 2022
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022